Abstract:Ursolic acid (UA) is a natural product which has been shown to possess a wide range of pharmacological activities, in particular those with anticancer activity. In this study, 13 novel ursolic acid derivatives were designed and synthesized in an attempt to further improve compound potency. The structures of the newly synthesized compounds were confirmed using mass spectrometry, infrared spectroscopy, and (1) H NMR. The ability of the UA derivatives to inhibit cell growth was assayed against both various tumor cell lines and a non-pathogenic cell line, HELF. Analysis of theoretical toxicity risks for all derivatives was performed using OSIRIS and indicated that the majority of compounds would present moderate to low risks. Pharmacological results indicated that the majority of the derivatives were more potent growth inhibitors than UA. In particular, 5b demonstrated IC50 values ranging from 4.09 ± 0.27 to 7.78 ± 0.43 μm against 12 different tumor cell lines. Flow cytometry analysis indicated that 5b induced G0/G1 arrest in three of these cell lines. These results were validated by structural docking studies, which confirmed that UA could bind to cyclins D1 (Cyc D1) and cyclin-dependent kinases (CDK6), the key regulators of G0/G1 transition in cell cycle, while the piperazine moiety of 5b could bind with glucokinase (GK), glucose transporter 1 (GLUT1), and ATPase, which are the main proteins involved in cancer cell metabolism. Acridine orange/ethidium bromide staining confirmed that 5b was capable of inducing apoptosis and decreasing cell viability in a dose-dependent manner.

Synthesis of Oleanolic Acid-Dithiocarbamate Conjugates and Evaluation of Their Broad-Spectrum Antitumor Activities

A Library of 1,2,3-Triazole-substituted Oleanolic Acid Derivatives As Anticancer Agents: Design, Synthesis, and Biological Evaluation

Synthesis and Anti-Tumor Activity of Oleanolic Acid Derivatives

Synthesis and Anticancer Activity of Novel Oleanolic Acid Derivatives

Design, synthesis, and antitumor activity of novel oleanolic acid analogues targeting EGFR

Synthesis, Characterization and Cytotoxic Activity of Novel Oleanolic Acid and Ursolic Acid Derivatives

Synthesis and Antitumor Activity of Novel Oleanolic Acid-Nitrate Conjugates

Synthesis and Tumor Cytotoxicity of Novel 1,2,3-Triazole-substituted 3-Oxo-oleanolic Acid Derivatives

Synthesis and Antitumor Activity Evaluation of Novel Oleanolic Acid Derivatives

Design and Synthesis of the Novel Oleanolic Acid-Cinnamic Acid Ester Derivatives and Glycyrrhetinic Acid-Cinnamic Acid Ester Derivatives with Cytotoxic Properties

Synthesis and antitumor activity of α,β-unsaturated carbonyl moiety- containing oleanolic acid derivatives targeting PI3K/AKT/mTOR signaling pathway

Synthesis and Cytotoxicity of Oleanolic Acid/N-aryl-N'-hydroxyguanidine Hybrids

Synthesis and biological evaluation of oleanolic acid derivatives as antitumor agents.

Design, synthesis, and antitumor activity of oleanolic acid derivatives

Synthesis and Biological Evaluation of Oleanolic Acid Derivatives with Electrophilic Warheads As Antitumor Agents.

Synthesis and Biological Evaluation of Novel Ursolic acid Derivatives as Potential Anticancer Prodrugs

Synthesis and Antitumor Activity Evaluation of Novel Ursolic Acid Derivatives

Synthesis and biological evaluation of novel Jiyuan Oridonin A-1,2,3-triazole-azole derivatives as antiproliferative agents.

Design, Synthesis and Anti‐Tumor Activity Evaluation of Novel 3,4‐(methylenedioxy)cinnamic Acid Amide‐Dithiocarbamate Derivatives

Synthesis and Biological Evaluations of Cytotoxic and Antiangiogenic Triterpenoids-Jacaranone Conjugates

Design and Synthesis of New Anticancer Glycyrrhetinic Acids and Oleanolic Acids.